XNAS · Healthcare · Biotechnology
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | Q1 2026 | -0.33 | -0.32 | +3.03% | $0 | ✅ Beat | -1.65% | +17.20% | — |
| 2026-05-07 | Q1 2026 | -0.33 | -0.32 | +3.03% | $0 | ✅ Beat | -0.24% | +29.44% | — |
| 2026-03-12 |
| Q4 2025 |
| -0.38 |
| -0.34 |
| +10.53% |
| $0 |
| ✅ Beat |
| +3.24% |
| -7.95% |
| -13.08% |
| 2025-11-06 | Q3 2025 | -0.34 | -0.26 | +23.53% | $0 | ✅ Beat | — | — | — |
| 2025-03-18 | Q4 2024 | — | -0.67 | — | $7.2M | — | +0.00% | -3.47% | -22.28% |
Showing last 5 quarters.